189 related articles for article (PubMed ID: 31431381)
1. Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation.
Heukelom J; Kantor ME; Mohamed ASR; Elhalawani H; Kocak-Uzel E; Lin T; Yang J; Aristophanous M; Rasch CR; Fuller CD; Sonke JJ
Radiother Oncol; 2020 Jan; 142():100-106. PubMed ID: 31431381
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
[TBL] [Abstract][Full Text] [Related]
3. Multivariable normal tissue complication probability model-based treatment plan optimization for grade 2-4 dysphagia and tube feeding dependence in head and neck radiotherapy.
Kierkels RGJ; Wopken K; Visser R; Korevaar EW; van der Schaaf A; Bijl HP; Langendijk JA
Radiother Oncol; 2016 Dec; 121(3):374-380. PubMed ID: 27614681
[TBL] [Abstract][Full Text] [Related]
4. Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer.
Hunter KU; Fernandes LL; Vineberg KA; McShan D; Antonuk AE; Cornwall C; Feng M; Schipper MJ; Balter JM; Eisbruch A
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):676-82. PubMed ID: 24035328
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of decentralised model-based selection of head and neck cancer patients for a proton treatment study. DAHANCA 35.
Hansen CR; Jensen K; Smulders B; Holm AIS; Samsøe E; Nielsen MS; Sibolt P; Skyt P; Elstrøm UV; Nielsen CP; Johansen J; Zukauskaite R; Eriksen JG; Farhadi M; Andersen M; Andersen E; Overgaard J; Grau C; Friborg J
Radiother Oncol; 2024 Jan; 190():109812. PubMed ID: 37479061
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effectiveness of novel single-intervention adaptive radiotherapy strategies based on daily dose accumulation.
Ciarmatori A; Maffei N; Mistretta GM; Ceroni P; Bernabei A; Meduri B; D'Angelo E; Bruni A; Giacobazzi P; Lohr F; Guidi G
Med Dosim; 2019 Winter; 44(4):379-384. PubMed ID: 30871864
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of normal tissue complication probability models derived from planned and delivered dose for head and neck cancer patients.
Kanehira T; van Kranen S; Jansen T; Hamming-Vrieze O; Al-Mamgani A; Sonke JJ
Radiother Oncol; 2021 Nov; 164():209-215. PubMed ID: 34619234
[TBL] [Abstract][Full Text] [Related]
8. SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.
de Veij Mestdagh PD; Janssen T; Lamers E; Carbaat C; Hamming-Vrieze O; Vogel WV; Sonke JJ; Al-Mamgani A
Radiother Oncol; 2019 Jan; 130():18-24. PubMed ID: 30087057
[TBL] [Abstract][Full Text] [Related]
9. Near Real-Time Assessment of Anatomic and Dosimetric Variations for Head and Neck Radiation Therapy via Graphics Processing Unit-based Dose Deformation Framework.
Qi XS; Santhanam A; Neylon J; Min Y; Armstrong T; Sheng K; Staton RJ; Pukala J; Pham A; Low DA; Lee SP; Steinberg M; Manon R; Chen AM; Kupelian P
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):415-22. PubMed ID: 25847607
[TBL] [Abstract][Full Text] [Related]
10. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
[TBL] [Abstract][Full Text] [Related]
11. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
[TBL] [Abstract][Full Text] [Related]
12. Clinical and dosimetric impact of adaptive intensity-modulated radiotherapy in locally advanced head-and-neck cancer.
Maheshwari G; Dhanawat A; Kumar HS; Sharma N; Jakhar SL
J Cancer Res Ther; 2020; 16(3):600-604. PubMed ID: 32719274
[TBL] [Abstract][Full Text] [Related]
13. Differences in delineation guidelines for head and neck cancer result in inconsistent reported dose and corresponding NTCP.
Brouwer CL; Steenbakkers RJ; Gort E; Kamphuis ME; van der Laan HP; Van't Veld AA; Sijtsema NM; Langendijk JA
Radiother Oncol; 2014 Apr; 111(1):148-52. PubMed ID: 24560759
[TBL] [Abstract][Full Text] [Related]
14. Experience-based quality control of clinical intensity-modulated radiotherapy planning.
Moore KL; Brame RS; Low DA; Mutic S
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):545-51. PubMed ID: 21277097
[TBL] [Abstract][Full Text] [Related]
15. Novel Radiobiological Gamma Index for Evaluation of 3-Dimensional Predicted Dose Distribution.
Sumida I; Yamaguchi H; Kizaki H; Aboshi K; Tsujii M; Yoshikawa N; Yamada Y; Suzuki O; Seo Y; Isohashi F; Yoshioka Y; Ogawa K
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):779-86. PubMed ID: 25936816
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
[TBL] [Abstract][Full Text] [Related]
17. Anatomical and dose changes of gross tumour volume and parotid glands for head and neck cancer patients during intensity-modulated radiotherapy: effect on the probability of xerostomia incidence.
Marzi S; Pinnarò P; D'Alessio D; Strigari L; Bruzzaniti V; Giordano C; Giovinazzo G; Marucci L
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):e54-62. PubMed ID: 22138192
[TBL] [Abstract][Full Text] [Related]
18. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
[TBL] [Abstract][Full Text] [Related]
19. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
[TBL] [Abstract][Full Text] [Related]
20. Computed tomography number changes observed during computed tomography-guided radiation therapy for head and neck cancer.
Feng M; Yang C; Chen X; Xu S; Moraru I; Lang J; Schultz C; Li XA
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1041-7. PubMed ID: 25832695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
